Global and gene-specific DNA methylation pattern discriminates cholecystitis from gallbladder cancer patients in Chile

Author:

Kagohara Luciane Tsukamoto1,Schussel Juliana L12,Subbannayya Tejaswini3,Sahasrabuddhe Nandini3,Lebron Cynthia1,Brait Mariana1,Maldonado Leonel1,Valle Blanca L.1,Pirini Francesca1,Jahuira Martha1,Lopez Jaime4,Letelier Pablo45,Brebi-Mieville Priscilla14,Ili Carmen14,Pandey Akhilesh6789,Chatterjee Aditi13,Sidransky David1,Guerrero-Preston Rafael1810

Affiliation:

1. Department of Otolaryngology–Head & Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA

2. Department of Oral Medicine, Post Graduation Program in Dentistry, Universidade Federal do Paraná, Curitiba, Brazil

3. Institute of Bioinformatics, Whitefield, Bangalore 560066, Karnataka, India

4. Universidad de La Frontera, Facultad de Medicina, Departamento de Anatomía Patológica, Laboratorio Patología Molecular, BIOREN-CEGIN, Temuco, Chile

5. Escuela Ciencias de la Salud, Universidad Católica de Temuco, Temuco, Chile

6. McKusick–Nathans Institute of Genetic Medicine, Baltimore, MD 21205, USA

7. Department of Biological Chemistry, Baltimore, MD 21205, USA

8. Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA

9. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA

10. University of Puerto Rico School of Medicine, Department of Obstetrics & Gynecology, San Juan, Puerto Rico

Abstract

ABSTRACT  Aim: The aim of the study was to evaluate the use of global and gene-specific DNA methylation changes as potential biomarkers for gallbladder cancer (GBC) in a cohort from Chile. Material & methods: DNA methylation was analyzed through an ELISA-based technique and quantitative methylation-specific PCR. Results: Global DNA Methylation Index (p = 0.02) and promoter methylation of SSBP2 (p = 0.01) and ESR1 (p = 0.05) were significantly different in GBC when compared with cholecystitis. Receiver curve operator analysis revealed promoter methylation of APC, CDKN2A, ESR1, PGP9.5 and SSBP2, together with the Global DNA Methylation Index, had 71% sensitivity, 95% specificity, a 0.97 area under the curve and a positive predictive value of 90%. Conclusion: Global and gene-specific DNA methylation may be useful biomarkers for GBC clinical assessment.

Publisher

Future Medicine Ltd

Subject

Cancer Research,Oncology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3